Monoclonal Antibodies

Understanding Monoclonal Antibodies

  • Monoclonal antibodies are identical immune system proteins, all made from copies of a single type of white blood cell.
  • They are designed to attach to specific antigens present on the surface of cells, making them highly specific.
  • Their name comes from “mono-“ meaning single, and “clonal” because they are produced by one type of cell and are all identical.

Production of Monoclonal Antibodies

  • Monoclonal antibodies are produced by hybridoma cells, which are formed by fusing a B-lymphocyte (immune cell) with a fast-growing cancer cell.
  • The resultant cell combines the lymphocyte’s ability to produce one type of antibody with the non-stop growth of the cancer cell.
  • These hybridoma cells are encouraged to reproduce in a lab environment before being harvested for the antibodies they produce.

Uses of Monoclonal Antibodies

  • Monoclonal antibodies can be used to detect or treat specific types of cancers by binding to cancerous cells, highlighting their presence, and sometimes directly attacking the cancer.
  • They are used in diagnostic testing, for example in pregnancy tests, as they can bind specifically to hormones produced in pregnancy.
  • They’re used in research and can locate or identify different cells and substances, allowing scientists to study the effects of disease or drugs.
  • Monoclonal antibodies can also be used to treat some diseases of the immune system (immunotherapy) by targeting harmful cells.

Risks and Limitations

  • Inherent in their use is the risk of side-effects, some of which can be severe: fever, nausea, rash, low blood pressure, and even heart and lung problems in extreme cases.
  • Patients can develop a resistance to monoclonal antibodies over time, reducing their effectiveness.
  • They are also expensive and time consuming to produce, limiting their widespread use and availability in some regions.

Significant Impact

  • Despite their side effects and costs, monoclonal antibodies represent a significant advancement in both diagnostics and treatment methods in modern medicine.
  • The ability to target specific cells or proteins with a high degree of precision is unparalleled in its potential for highly personalised medical treatments.